Mikkel Andreassen
Overview
Explore the profile of Mikkel Andreassen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grindskar C, Andreassen M, Feltoft C, Eldrup E, Ugleholdt R, Jorgensen N, et al.
Horm Metab Res
. 2025 Mar;
57(3):156-162.
PMID: 40049224
A proportion of patients with primary aldosteronism (PA) have a paradox increasein plasma-Aldosterone (P-Aldosterone) concentration (PAC) during the Captopril Challenge Test (CCT). This study aimed to investigate if a paradoxical...
2.
Pieterman C, Grozinsky-Glasberg S, OToole D, Howe J, Ambrosini V, Belli S, et al.
J Neuroendocrinol
. 2024 Nov;
37(1):e13468.
PMID: 39587981
Multiple Endocrine Neoplasia type 1 (MEN1) Clinical Practice Guidelines (2012) are predominantly based on expert opinion due to limited available evidence at the time, leaving room for interpretation and variation...
3.
Askildsen E, Soldath P, Langer S, Andreassen M, Knigge U, Petersen R
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272839
Atypical lung carcinoid (AC) is widely accepted to recur more often after radical resection than typical lung carcinoid (TC). However, their recurrence rates have never been compared in a multi-state...
4.
Svendstrup M, Rasmussen A, Kistorp C, Klose M, Andreassen M
Pituitary
. 2024 Aug;
27(5):685-692.
PMID: 39120810
Purpose: Patients with tumors involving the hypothalamic region are at high risk of developing morbid obesity due to disturbances in the appetite regulative nuclei in hypothalamus. We evaluated the effect...
5.
Arlien-Soborg M, Dal J, Heck A, Stochholm K, Husted E, Feltoft C, et al.
Clin Endocrinol (Oxf)
. 2024 Jun;
101(3):263-273.
PMID: 38865284
Objective: Acromegaly is associated with increased morbidity and mortality if left untreated. The therapeutic options include surgery, medical treatment, and radiotherapy. Several guidelines and recommendations on treatment algorithms and follow-up...
6.
Andreassen M, Garbyal R, Larsen P, Hansen C, Hannibal J, Oturai P, et al.
J Surg Case Rep
. 2024 Jun;
2024(5):rjae371.
PMID: 38826856
This case report presents a 40-year-old patient with a vasoactive intestinal peptide (VIP) secreting high grade (Ki-67 39%) neuroendocrine tumor (NET) from the pancreas, for whom successful liver transplantation (LT)...
7.
Perrone E, Ghai K, Eismant A, Andreassen M, Langer S, Knigge U, et al.
Diagnostics (Basel)
. 2024 May;
14(9).
PMID: 38732321
The present report describes the history of a 58-year-old woman with a rapidly progressing neuroendocrine pancreatic tumor (initially G2) presenting with extensive liver, bone, and lymph node metastases. Previous treatments...
8.
Rosendal C, Christiansen Arlien-Soborg M, Nielsen E, Andersen M, Feltoft C, Klose M, et al.
Front Endocrinol (Lausanne)
. 2024 Apr;
15:1380436.
PMID: 38638137
Objective: To study the time-dependent changes in disease features of Danish patients with acromegaly, including treatment modalities, biochemical outcome, and comorbidities, with a particular focus on cancer and mortality. Methods:...
9.
Kornerup L, Andreassen M, Knigge U, Arveschoug A, Poulsen P, Kjaer A, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38611027
Introduction: Pheochromocytomas and paragangliomas are rare neuroendocrine tumours that originate from chromaffin cells within the adrenal medulla or extra-adrenal sympathetic ganglia. Management of disseminated or metastatic pheochromocytomas and paragangliomas continues...
10.
Petersen S, Moller S, Slott C, Krogh J, Hansen C, Kjaer A, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539524
Background: Given the rarity and heterogeneity of pancreatic neuroendocrine neoplasms (pNEN), treatment algorithms and sequencing are primarily guided by expert opinions with limited evidence. Aim: To investigate overall survival (OS),...